SHARE BAZAR STOCK

Glenmark launches  NCOVD-19 medicine News Glenmark has received approval to manufacture and market Favipiravir in India treatment of patients with mild to moderate COVID-19.Favipiravir has shown clinical improvement of up to 88 per cent in mild to moderate COVID-19 cases . Price at  ₹ 103 per tablet, 200 mg tablet at MRP of  ₹ 3,500 for 34 tablets. The dose of  Favipiravir is 1,800 mg twice daily on day one, followed by 800 mg twice daily up to day 14. It is a prescription-based medicine. Book Value:    208.95 Stock P/E:  16.10 Dividend Yield:  0.49  % ROCE:  14.78  % ROE:  15.20  % Sales Growth (3Yrs):  9.27  %

Bharat Heavy Electricals Ltd BHEL serves the core sectors of the economy and provides a wide range of solutions to customers in power, transmission, transportation, renewables, water, defence & aerospace, oil & gas, and industry.               One day Chart on 17.06.2020 Market Cap:    9,558  Cr. Current Price:    27.45 52 weeks High / Low    75.50  /  18.40 Book Value:    82.31 Dividend Yield:  7.29  % ROCE:  6.70  % ROE:  3.16  % Sales Growth (3Yrs):  5.99  % Promoter holding:  63.17  % Pledged percentage:  0.00  % Debt:    5,023  Cr. Positive: Stock is trading at 0.33 times its book value Stock is providing a good dividend yield of 7.29%. Company has been maintaining a healthy dividend payout of 101.62% Debtor days have improved from 201.85 to 144.38 days. Negative:...